Article Text

Download PDFPDF
PMM.62 How are antiepileptic drugs managed in pregnant women with epilepsy in Nottingham?
  1. MC Nelson
  1. University of Nottingham, Nottingham, UK


Background Epilepsy is a common neurological disease in pregnancy. There is an increased risk of teratogenesis in pregnant women taking antiepileptic drugs (AEDs). Stopping medication can result in seizures, potentially increasing maternal and fetal morbidity. Clearance of newer drugs (lamotrigine and levetiracetam) increases in pregnancy but routinely measuring drug serum concentrations is not recommended nationally.1 Local protocol is to measure AED levels and adjust AED doses accordingly. This audit looked at the management of pregnant women with epilepsy (WWE) taking AEDs.

Methods This was a retrospective audit of 45 patients seen at the joint antenatal clinic from October 2011 to 2013. Data was collected on baseline demographics, information given on AEDs, AED levels in pregnancy and pregnancy outcomes.

Results 35.6% of pregnant WWE received preconception counselling. 64.4% of patients were given 5mg/day folic acid. Pre-conception drug levels were taken in 33.3% of those taking lamotrigine and 22.2% taking levetiracetam. Taking regular drug levels and increasing doses was more common in lamotrigine than levetiracetam.

Conclusions Improving the number of women who receive preconception counselling and folic acid before pregnancy will need a multidisciplinary approach focussing on education in adolescence. If AED levels are to be useful in pregnancy, levels should be measured as soon as stable AED regimes are established. In order to prevent sub-therapeutic levels being undetected, a minimum of four levels should be measured during pregnancy, with approximately four weeks between each level being obtained. This audit should be repeated in 2–3 years to assess changes in care.


  1. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care CG137 Guidance. National Institute for Health and Care Excellence, 2012 [viewed 9th December 2013]. Available from:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.